InDex Pharmaceuticals has been granted a new patent for cobitolimod in South Korea

/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that a new method of use patent for the drug candidate cobitolimod has been granted by...

Related Keywords

Sweden ,Hong Kong ,South Korea ,Stockholm ,Johan Gil ,Jenny Sundqvist ,Prnewswire Index Pharmaceuticals Holding ,Korean Intellectual Property Office ,Kindex Pharmaceuticals ,Korean Intellectual Property ,Dex Pharmaceuticals ,Immunomodulatory Sequences ,Nasdaq First North Growth Market ,Medical Pharmaceuticals ,Health Care Amp Hospitals ,Pharmaceuticals ,Patent Law ,